Cohen Children’s Medical Center Performs First Gene Therapy Treatment For Thalassemia in NYS
The first administration in New York State of Zynteglo, recently approved by the FDA as a one-time gene therapy custom designed to treat the underlying genetic cause of transfusion-dependent beta-thalassemia in adult and pediatric patients, was performed …